Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sleep in ALI/ARDS
NCT01050699Phase 4Completed
- Sponsor
- University of Arizona
- Start
- Aug 2009
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in acute lung injury (ALI), acute respiratory distress syndrome (ARDS), sponsored by University of Arizona. Started Aug 2009; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT01050699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050699.